{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:16:14Z","timestamp":1793412974949,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:sec id=\"ab-nbr220004-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Step-based recommendations may be appropriate for dementia-prevention guidelines. However, the association of step count and intensity with dementia incidence is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nbr220004-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the dose-response association between daily step count and intensity and incidence of all-cause dementia among adults in the UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nbr220004-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>UK Biobank prospective population-based cohort study (February 2013 to December 2015) with 6.9 years of follow-up (data analysis conducted May 2022). A total of 78\u202f430 of 103\u202f684 eligible adults aged 40 to 79 years with valid wrist accelerometer data were included. Registry-based dementia was ascertained through October 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nbr220004-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Accelerometer-derived daily step count, incidental steps (less than 40 steps per minute), purposeful steps (40 steps per minute or more), and peak 30-minute cadence (ie, mean steps per minute recorded for the 30 highest, not necessarily consecutive, minutes in a day).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nbr220004-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Incident dementia (fatal and nonfatal), obtained through linkage with inpatient hospitalization or primary care records or recorded as the underlying or contributory cause of death in death registers. Spline Cox regressions were used to assess dose-response associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nbr220004-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study monitored 78\u202f430 adults (mean [SD] age, 61.1 [7.9] years; 35\u202f040 [44.7%] male and 43\u202f390 [55.3%] female; 881 [1.1%] were Asian, 641 [0.8%] were Black, 427 [0.5%] were of mixed race, 75\u202f852 [96.7%] were White,  and 629 [0.8%] were of another, unspecified race) over a median (IQR) follow-up of 6.9 (6.4-7.5) years, 866 of whom developed dementia (mean [SD] age, 68.3 [5.6] years; 480 [55.4%] male and 386 [54.6%] female; 5 [0.6%] Asian, 6 [0.7%] Black, 4 [0.4%] mixed race, 821 [97.6%] White, and 6 [0.7%] other). Analyses revealed nonlinear associations between daily steps. The optimal dose (ie, exposure value at which the maximum risk reduction was observed) was 9826 steps (hazard ratio [HR], 0.49; 95% CI, 0.39-0.62) and the minimal dose (ie, exposure value at which the risk reduction was 50% of the observed maximum risk reduction) was 3826 steps (HR, 0.75; 95% CI, 0.67-0.83). The incidental cadence optimal dose was 3677 steps (HR, 0.58; 95% CI, 0.44-0.72); purposeful cadence optimal dose was 6315 steps (HR, 0.43; 95% CI, 0.32-0.58); and peak 30-minute cadence optimal dose was 112 steps per minute (HR, 0.38; 95% CI, 0.24-0.60).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-nbr220004-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, a higher number of steps was associated with lower risk of all-cause dementia. The findings suggest that a dose of just under 10\u202f000 steps per day may be optimally associated with a lower risk of dementia. Steps performed at higher intensity resulted in stronger associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2022.2672","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T11:37:35Z","timestamp":1662464255000},"page":"1059","source":"Crossref","is-referenced-by-count":185,"title":["Association of Daily Step Count and Intensity With Incident Dementia in 78\u202f430 Adults Living in the UK"],"prefix":"10.1001","volume":"79","author":[{"given":"Borja","family":"del Pozo Cruz","sequence":"first","affiliation":[{"name":"Department of Sports Science and Clinical Biomechanics, Centre for Active and Healthy Ageing, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Charles Perkins Centre, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, Camperdown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Naismith","sequence":"additional","affiliation":[{"name":"Charles Perkins Centre, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Stamatakis","sequence":"additional","affiliation":[{"name":"Charles Perkins Centre, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, Camperdown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"nbr220004r1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40279-016-0663-1","article-title":"Step counting: a review of measurement considerations and health-related applications.","volume":"47","author":"Bassett","year":"2017","journal-title":"Sports Med"},{"issue":"3","key":"nbr220004r2","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/S2468-2667(21)00302-9","article-title":"Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts.","volume":"7","author":"Paluch","year":"2022","journal-title":"Lancet Public Health"},{"issue":"12","key":"nbr220004r3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2020.1382","article-title":"Association of daily step count and step intensity with mortality among US adults.","volume":"323","author":"Saint-Maurice","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"nbr220004r5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1001\/jamaneurol.2019.1879","article-title":"Associations of physical activity and \u00df-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults.","volume":"76","author":"Rabin","year":"2019","journal-title":"JAMA Neurol"},{"issue":"12","key":"nbr220004r6","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/jama.292.12.1447","article-title":"Walking and dementia in physically capable elderly men.","volume":"292","author":"Abbott","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"nbr220004r7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"nbr220004r8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10654-019-00499-1","article-title":"Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data.","volume":"34","author":"Wilkinson","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"nbr220004r9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsams.2016.06.003","article-title":"Field evaluation of a random forest activity classifier for wrist-worn accelerometer data.","volume":"20","author":"Pavey","year":"2017","journal-title":"J Sci Med Sport"},{"key":"nbr220004r10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.gaitpost.2021.11.035","article-title":"Validation of open-source step-counting algorithms for wrist-worn tri-axial accelerometers in cardiovascular patients.","volume":"92","author":"Femiano","year":"2022","journal-title":"Gait Posture"},{"issue":"8","key":"nbr220004r11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamainternmed.2019.0899","article-title":"Association of step volume and intensity with all-cause mortality in older women.","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"8","key":"nbr220004r12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1123\/jpah.9.8.1125","article-title":"Peak stepping cadence in free-living adults: 2005-2006 NHANES.","volume":"9","author":"Tudor-Locke","year":"2012","journal-title":"J Phys Act Health"},{"issue":"6","key":"nbr220004r13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies.","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"nbr220004r14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1249\/MSS.0000000000001932","article-title":"Daily step counts for measuring physical activity exposure and its relation to health.","volume":"51","author":"Kraus","year":"2019","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"nbr220004r15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/EDE.0000000000001316","article-title":"Is cohort representativeness pass\u00e9? poststratified associations of lifestyle risk factors with mortality in the UK Biobank.","volume":"32","author":"Stamatakis","year":"2021","journal-title":"Epidemiology"},{"key":"nbr220004r4","author":"Garduno","year":"2019"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2795819\/jamaneurology_del_pozo_cruz_2022_br_220004_1664471664.40293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T11:26:58Z","timestamp":1665401218000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2795819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.2672","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742309168.793595349","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}